237 related articles for article (PubMed ID: 16829119)
1. Novel targets in gastric and esophageal cancer.
Valverde CM; Macarulla T; Casado E; Ramos FJ; Martinelli E; Tabernero J
Crit Rev Oncol Hematol; 2006 Aug; 59(2):128-38. PubMed ID: 16829119
[TBL] [Abstract][Full Text] [Related]
2. Targeted therapies in the treatment of gastric cancer.
Ngeow J; Tan IB; Choo SP
Asia Pac J Clin Oncol; 2011 Sep; 7(3):224-35. PubMed ID: 21884434
[TBL] [Abstract][Full Text] [Related]
3. Novel targeted therapies in the treatment of gastric and esophageal cancer.
Tabernero J; Macarulla T; Ramos FJ; Baselga J
Ann Oncol; 2005 Nov; 16(11):1740-8. PubMed ID: 15980157
[TBL] [Abstract][Full Text] [Related]
4. Targeted therapy for oesophageal cancer: an overview.
Syrigos KN; Zalonis A; Kotteas E; Saif MW
Cancer Metastasis Rev; 2008 Jun; 27(2):273-88. PubMed ID: 18224295
[TBL] [Abstract][Full Text] [Related]
5. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
[TBL] [Abstract][Full Text] [Related]
6. Recent results in understanding molecular pathways in the medical treatment of esophageal and gastric cancer.
Sutter AP; Zeitz M; Scherübl H
Onkologie; 2004 Feb; 27(1):17-21. PubMed ID: 15007244
[TBL] [Abstract][Full Text] [Related]
7. Targeted agents and esophageal cancer--the next step?
Aklilu M; Ilson DH
Semin Radiat Oncol; 2007 Jan; 17(1):62-9. PubMed ID: 17185199
[TBL] [Abstract][Full Text] [Related]
8. Development of targeted therapies in advanced gastric cancer: promising exploratory steps in a new era.
Wagner AD; Moehler M
Curr Opin Oncol; 2009 Jul; 21(4):381-5. PubMed ID: 19412098
[TBL] [Abstract][Full Text] [Related]
9. Novel targets in esophageal and gastric cancer: beyond antiangiogenesis.
Lee W; Patel JH; Lockhart AC
Expert Opin Investig Drugs; 2009 Sep; 18(9):1351-64. PubMed ID: 19642951
[TBL] [Abstract][Full Text] [Related]
10. Targeted therapies for esophageal cancer.
Tew WP; Kelsen DP; Ilson DH
Oncologist; 2005 Sep; 10(8):590-601. PubMed ID: 16177283
[TBL] [Abstract][Full Text] [Related]
11. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
Wallerand H; Reiter RR; Ravaud A
Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
[TBL] [Abstract][Full Text] [Related]
12. Key cancer cell signal transduction pathways as therapeutic targets.
Bianco R; Melisi D; Ciardiello F; Tortora G
Eur J Cancer; 2006 Feb; 42(3):290-4. PubMed ID: 16376541
[TBL] [Abstract][Full Text] [Related]
13. Esophagogastric cancer: targeted agents.
Ku GY; Ilson DH
Cancer Treat Rev; 2010 May; 36(3):235-48. PubMed ID: 20122806
[TBL] [Abstract][Full Text] [Related]
14. [Molecular therapy targets in lung cancer].
Le Guen Y; Sabatier L; Le Chevalier T; Soria JC
Bull Cancer; 2003 Dec; 90(12):1055-61. PubMed ID: 14715425
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor (EGFR)-targeted therapies in esophagogastric cancer.
Ayyappan S; Prabhakar D; Sharma N
Anticancer Res; 2013 Oct; 33(10):4139-55. PubMed ID: 24122977
[TBL] [Abstract][Full Text] [Related]
16. Novel targets for anticancer treatment development in colorectal cancer.
Macarulla T; Ramos FJ; Capdevila J; Saura C; Tabernero J
Clin Colorectal Cancer; 2006 Nov; 6(4):265-72. PubMed ID: 17241511
[TBL] [Abstract][Full Text] [Related]
17. Esophageal cancer: current and emerging therapy modalities.
Ekman S; Dreilich M; Lennartsson J; Wallner B; Brattström D; Sundbom M; Bergqvist M
Expert Rev Anticancer Ther; 2008 Sep; 8(9):1433-48. PubMed ID: 18759695
[TBL] [Abstract][Full Text] [Related]
18. Activation of growth factor receptors in esophageal cancer--implications for therapy.
Ekman S; Bergqvist M; Heldin CH; Lennartsson J
Oncologist; 2007 Oct; 12(10):1165-77. PubMed ID: 17962610
[TBL] [Abstract][Full Text] [Related]
19. Molecular genetics and mechanisms of apoptosis in carcinomas of the lung and pleura: therapeutic targets.
Motadi LR; Misso NL; Dlamini Z; Bhoola KD
Int Immunopharmacol; 2007 Dec; 7(14):1934-47. PubMed ID: 18039530
[TBL] [Abstract][Full Text] [Related]
20. Emerging drugs for esophageal cancer.
Homs MY; Voest EE; Siersema PD
Expert Opin Emerg Drugs; 2009 Jun; 14(2):329-39. PubMed ID: 19453287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
